Serge Depatie
Member since: May '08
Assistant Vice President, Small Caps at
Natcan Investment Management

Latest Top Picks

Located in Montreal which is a hub for clinical trials in this company has taken the opportunity there. Has grown tremendously and he sees no end in sight in terms of obtaining contracts by the pharmaceutical industry, which more and more has to outsource research work. They have quality contracts.
Treats atrial fibrillation (irregular heartbeat). This is a large coming market in cardiac area that is unsolved. The clinical trials they are doing in the US and Europe are indicating that the doctors are really adopting the product. Will probably be the leading therapy in this area. Expecting a takeout, especially if they get FDA approval.